Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

OptimizeRx Sees FY2026 Sales $118.000M-$124.000M vs $118.125M Est

Author: Benzinga Newsdesk | November 06, 2025 04:06pm

OptimizeRx (NASDAQ:OPRX) sees FY2026 sales of $118.000 million-$124.000 million vs $118.125 million analyst estimate.

Posted In: OPRX